155 related articles for article (PubMed ID: 33824389)
1. Improves symptoms and urinary biomarkers in refractory interstitial cystitis/bladder pain syndrome patients randomized to extracorporeal shock wave therapy versus placebo.
Shen YC; Tyagi P; Lee WC; Chancellor M; Chuang YC
Sci Rep; 2021 Apr; 11(1):7558. PubMed ID: 33824389
[TBL] [Abstract][Full Text] [Related]
2. Pain reduction realized with extracorporeal shock wave therapy for the treatment of symptoms associated with interstitial cystitis/bladder pain syndrome-A prospective, multicenter, randomized, double-blind, placebo-controlled study.
Chuang YC; Meng E; Chancellor M; Kuo HC
Neurourol Urodyn; 2020 Jun; 39(5):1505-1514. PubMed ID: 32394478
[TBL] [Abstract][Full Text] [Related]
3. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
[TBL] [Abstract][Full Text] [Related]
4. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
5. Effects of electroacupuncture on refractory interstitial cystitis/bladder pain syndrome: A one-year follow-up case report.
Gao N; Zeng X; Wu L; Lin Z; Wang X; Wang W
Explore (NY); 2024; 20(4):602-605. PubMed ID: 38072764
[TBL] [Abstract][Full Text] [Related]
6. Complete response to acupuncture therapy in female patients with refractory interstitial cystitis/bladder pain syndrome.
Sönmez MG; Kozanhan B
Ginekol Pol; 2017; 88(2):61-67. PubMed ID: 28326514
[TBL] [Abstract][Full Text] [Related]
7. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
[TBL] [Abstract][Full Text] [Related]
8. Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity.
Wu Y; He Y; Qi J; Wang S; Wang Z
Biomol Biomed; 2024 Jan; 24(1):170-175. PubMed ID: 37819233
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.
Bosch PC
J Urol; 2014 Jan; 191(1):77-82. PubMed ID: 23792149
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
[TBL] [Abstract][Full Text] [Related]
11. Treatment with low-energy shock wave alleviates pain in an animal model of uroplakin 3A-induced autoimmune interstitial cystitis/painful bladder syndrome.
Li H; Zhang Z; Peng J; Xin Z; Li M; Yang B; Fang D; Tang Y; Guo Y
Investig Clin Urol; 2019 Sep; 60(5):359-366. PubMed ID: 31501798
[TBL] [Abstract][Full Text] [Related]
12. Urine nerve growth factor (NGF) level, bladder nerve staining and symptom/problem scores in patients with interstitial cystitis.
Tonyali S; Ates D; Akbiyik F; Kankaya D; Baydar D; Ergen A
Adv Clin Exp Med; 2018 Feb; 27(2):159-163. PubMed ID: 29521057
[TBL] [Abstract][Full Text] [Related]
13. Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study.
Jhang JF; Wu SY; Lin TY; Kuo HC
Low Urin Tract Symptoms; 2019 Apr; 11(2):O42-O47. PubMed ID: 29265766
[TBL] [Abstract][Full Text] [Related]
14. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Bosch PC
Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
[TBL] [Abstract][Full Text] [Related]
15. Effect of Sacral Neuromodulation on Outcome Measures and Urine Chemokines in Interstitial Cystitis/Painful Bladder Syndrome Patients.
Peters KM; Jayabalan N; Bui D; Killinger K; Chancellor M; Tyagi P
Low Urin Tract Symptoms; 2015 May; 7(2):77-83. PubMed ID: 26663686
[TBL] [Abstract][Full Text] [Related]
16. Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome.
Nickel JC; Moldwin R; Hanno P; Dmochowski R; Peters KM; Payne C; Wein A
J Urol; 2019 Aug; 202(2):301-308. PubMed ID: 31090511
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double-blind, placebo-controlled, clinical study.
Yoshimura N; Homma Y; Tomoe H; Otsuka A; Kitta T; Masumori N; Akiyama Y; Niimi A; Mitsui T; Nanri M; Namima T; Takei M; Yamaguchi A; Sekiguchi Y; Kajiwara M; Kobayashi S; Ameda K; Ohashi Y; Sakamoto S; Muraki O; Shishido T; Kageyama S; Kokura K; Okazoe H; Yamanishi T; Watanabe T; Uno T; Ohinata A; Ueda T
Int J Urol; 2021 May; 28(5):545-553. PubMed ID: 33580603
[TBL] [Abstract][Full Text] [Related]
18. Use of low-intensity extracorporeal shock wave therapy in the management of interstitial cystitis/bladder pain syndrome patients: A thirty case study in a tertiary medical center.
Jhang LS; Hsieh WC; Huang TX; Chou YC; Lo TS; Liang CC; Lin YH
Neurourol Urodyn; 2023 Jan; 42(1):65-72. PubMed ID: 36177673
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Clorpactin in refractory bladder pain syndrome/interstitial cystitis: a randomized controlled trial.
Cvach K; Rosamilia A; Dwyer P; Lim Y; DeSouza A; Ow L; Thomas E; Murray C; Leitch A; Schierlitz L
Int Urogynecol J; 2021 May; 32(5):1177-1183. PubMed ID: 33452887
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal Shockwave Therapy Combined with Drug Therapy in Chronic Pelvic Pain Syndrome : A Randomized Clinical Trial.
Rayegani SM; Razzaghi MR; Raeissadat SA; Allameh F; Eliaspour D; Abedi AR; Javadi A; Rahavian AH
Urol J; 2020 Mar; 17(2):185-191. PubMed ID: 31004340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
